Drug-Drug Interaction Between Eugenol and Repaglinide in Type 2 Diabetes Mellitus and Its Potential Mechanism
Journal of Visualized Experiments · 2026
DOI: 10.3791/72128 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Zhen Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Jilin Academy of Chinese Medical Sciences. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Carbamates, Diabetes Mellitus, Type 2, Eugenol.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Jilin Academy of Chinese Medical Sciences.
- Department of Geriatrics, Jilin Academy of Chinese Medical Sciences; sunli6426@163.com.
Zitieren
APA
Zhao, Z., Zhang, S., Li, S., & Sun, L. (2026). Drug-Drug Interaction Between Eugenol and Repaglinide in Type 2 Diabetes Mellitus and Its Potential Mechanism. Journal of Visualized Experiments. https://doi.org/10.3791/72128
Vancouver
Zhao Z, Zhang S, Li S, Sun L. Drug-Drug Interaction Between Eugenol and Repaglinide in Type 2 Diabetes Mellitus and Its Potential Mechanism. Journal of Visualized Experiments. 2026. doi:10.3791/72128
BibTeX
@article{Zhao2026,
author = {Zhao, Zhen and Zhang, Shuisheng and Li, Shuai and Sun, Li},
title = {Drug-Drug Interaction Between Eugenol and Repaglinide in Type 2 Diabetes Mellitus and Its Potential Mechanism},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/72128}
}
EUVIMED